FDA Approved: CEFACLOR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Cefaclor by Teva, updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Otitis Media
• Pneumonia
• Sinusitis
• Skin and Soft Tissue Infection
• Urinary Tract Infection

Drugs mentioned

• CEFACLOR (cefaclor)

Snippet

SUPPL AP for CEFACLOR (CEFACLOR)